PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33424398-0	2021	In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2.	Flavonoids	24-34	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	72-77	
33424398-4	2021	In the current study, an in silico approach is carried out as a means of inhibiting the spike protein of the novel coronavirus by flavonoids from natural sources that possess both antiviral and anti-inflammatory properties.	Flavonoids	130-140	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	88-93	
33424398-5	2021	The methodology is focused on molecular docking of 10 flavonoid compounds that are docked with the spike protein of SARS-CoV-2, to determine the highest binding affinity at the binding site.	Flavonoids	54-63	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	99-104	
33424398-7	2021	The flavonoid naringin showed the least binding energy of -9.8 Kcal/mol with the spike protein which was compared with the standard drug, dexamethasone which is being repurposed to treat critically ill patients.	Flavonoids	4-13	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	81-86